Methionine Aminopeptidases and Angiogenesis
Overview
Authors
Affiliations
The initiator methionine residue of proteins is removed during synthesis by a specific and ubiquitous enzyme, methionine aminopeptidase (MetAP). Prokaryotes have a single gene, while eukaryotes have two isoforms. This family of metalloenzymes generally cleaves substrates in which the penultimate residue is one of the seven smaller amino acids (glycine, alanine, serine, threonine, proline, cysteine and valine). One of the eukaryotic isoforms (MetAP2) has an additional non-proteolytic function and is the principle target of a family of anti-angiogenic drugs that are related to fumagillin. The resulting covalent modification inhibits the protease activity of MetAP2 and blocks cell-cycle function in endothelial and some cancer cells. The role of MetAP2 in the mitogenic activity of these cells is unknown.
Moon D Biomolecules. 2025; 14(12.
PMID: 39766279 PMC: 11673396. DOI: 10.3390/biom14121572.
Zhang K, Hu J, Zhao Z PLoS One. 2023; 18(7):e0289024.
PMID: 37506053 PMC: 10381083. DOI: 10.1371/journal.pone.0289024.
Newly synthesized methionine aminopeptidase 2 inhibitor hinders tumor growth.
Esa R, Steinberg E, Dagan A, Yekhtin Z, Tischenko K, Benny O Drug Deliv Transl Res. 2022; 13(5):1170-1182.
PMID: 35637333 DOI: 10.1007/s13346-022-01187-6.
Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents.
Han J, Tang Y, Lu M, Hua H Diabetes Metab Syndr Obes. 2018; 11:565-577.
PMID: 30319281 PMC: 6167978. DOI: 10.2147/DMSO.S171109.
Narayanan S, Nampoothiri K Mol Cell Biochem. 2012; 365(1-2):191-202.
PMID: 22466806 DOI: 10.1007/s11010-012-1260-8.